REVIEW
Accepted on 19 Nov 2025
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Biomarkers in the Era of Cancer Immunotherapy: Zooming in from Periphery to Tumor Microenvironment, Volume III
Community Series in Biomarkers in the Era of Cancer Immunotherapy: Zooming in from Periphery to Tumor Microenvironment, Volume III
4,196
Total downloads
20k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 07 Nov 2025
NK cell function down regulated by HMGB2 through ANGPT1/PI3K/AKT pathway and its effect on esophageal squamous carcinoma cells
doi 10.3389/fimmu.2025.1666199
- 519 views
SYSTEMATIC REVIEW
Published on 30 Sep 2025
Association between the expression status of programmed cell death ligand 1 and the efficacy of pan-cancer neoadjuvant immune checkpoint blockade
doi 10.3389/fimmu.2025.1617905
- 1,125 views
REVIEW
Published on 13 Aug 2025
Multidimensional insights into exosomes in hepatocellular carcinoma: from genesis to clinical application
doi 10.3389/fimmu.2025.1628573
- 2,165 views
ORIGINAL RESEARCH
Published on 08 Aug 2025
Multiplexed immune profiling and 3D co-culture assays to assess the individual checkpoint therapy response in head and neck squamous cell carcinoma
doi 10.3389/fonc.2025.1622008
- 1,681 views
SYSTEMATIC REVIEW
Published on 26 Jun 2025
The prognostic and clinicopathological value of HALP score in non-small cell lung cancer
doi 10.3389/fimmu.2025.1576326
- 3,095 views
ORIGINAL RESEARCH
Published on 11 Jun 2025
Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC
doi 10.3389/fimmu.2025.1578422
- 2,256 views
- 1 citation
ORIGINAL RESEARCH
Published on 04 Jun 2025
Comprehensive pan-cancer analysis and experimental validation reveal FCHSD1 as a potential biomarker for diagnosis, immune infiltration, and prognosis
doi 10.3389/fonc.2025.1547067
- 1,188 views
ORIGINAL RESEARCH
Published on 22 May 2025
Expression of PSMD14 in lung adenocarcinoma and its impact on immune cell infiltration and prognosis: a comprehensive analysis based on RNA and single-cell RNA sequencing
doi 10.3389/fimmu.2025.1560693
- 2,238 views
ORIGINAL RESEARCH
Published on 16 Apr 2025
Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma
doi 10.3389/fimmu.2025.1559317
- 2,303 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: